Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-54306 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6827 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6851 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 |
filingDate |
2018-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2020-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2020524503-A |
titleOfInvention |
Methods and kits for capture of CA-IX positive exosomes |
abstract |
The present invention provides methods for isolating tumor-derived exosomes by immunocapture with anti-CA-IX antibodies, methods for quantifying tumor-associated nucleic acid sequences from such isolated exosomes, and the presence of tumors in a subject. In vitro. The invention also relates to kits for use in these methods. |
priorityDate |
2017-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |